Shantan Reddy

Manipal Academy of Higher Education — India

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index2.2kcitations33works19.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CRISPR and Genetic Engineering(9), SARS-CoV-2 and COVID-19 Research(6), Virus-based gene therapy research(6), CAR-T cell therapy research(6), Viral gastroenteritis research and epidemiology(5)

Publications33 total

An integrated enzymatic and computational pipeline for quantifying off-target base-editing
2025Open Access
Utility of Cancer Ratio (Serum LDH/Pleural Fluid ADA) and Cancer Plus Ratio (Cancer Ratio/Pleural Fluid Lymphocytic Percentage) in Differentiating Malignant Pleural Effusion and Tubercular Pleural Effusion: A Prospective Observational Study
2025Open Access
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
Nature Medicine·2025· 58 cited
Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome
Blood·2023· 37 citedOpen Access
Widespread, human-associated redondoviruses infect the commensal protozoan Entamoeba gingivalis
Cell Host & Microbe·2022· 29 citedOpen Access
Multiple Introductions of SARS-CoV-2 Alpha and Delta Variants into White-Tailed Deer in Pennsylvania
mBio·2022· 69 citedOpen Access
Rapid manufacturing of non-activated potent CAR T cells
Nature Biomedical Engineering·2022· 255 citedOpen Access
Multiple Introductions of SARS-CoV-2 Alpha and Delta Variants into White-Tailed Deer in Pennsylvania
2022· 11 citedOpen Access
SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021
mBio·2022· 15 citedOpen Access
Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial
Nature Medicine·2022· 46 citedOpen Access
SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021
2021· 6 citedOpen Access
Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome
mBio·2021· 121 citedOpen Access
Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 Isolates
Open Forum Infectious Diseases·2021· 20 citedOpen Access
Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency
Blood·2021· 48 citedOpen Access
Signatures of COVID-19 severity and immune response in the respiratory tract microbiome
2021· 19 citedOpen Access
SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia
mBio·2021· 31 citedOpen Access
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration
Journal of Clinical Investigation·2019· 125 citedOpen Access
iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity
Genome biology·2019· 79 citedOpen Access
Additional file 1: of iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity
Figshare·2019Open Access
Additional file 2: of iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity
Figshare·2019Open Access
page 1 of 2Next →

Frequent Co-authors

Frederic D. Bushman(23), J.K. Everett(13), Christopher L. Nobles(8), Carl H. June(8), J. Joseph Melenhorst(8), Ronald G. Collman(8), Aoife M. Roche(8), Yangbing Zhao(6), Scott Sherrill-Mix(6), Megan M. Davis(6), Hope E. Uronis(5), Darren Sigal(5), William R. Schelman(5), David P. Ryan(5), Samantha A. Whiteside(5), Abigail Glascock(5), Jevon Graham-Wooten(5), Layla A. Khatib(5), Ayannah S. Fitzgerald(5), January Salas-McKee(5)